University of Washington Developmental AIDS Research Center for Mental Health (UW ARCH)
华盛顿大学心理健康发展艾滋病研究中心 (UW ARCH)
基本信息
- 批准号:10816852
- 负责人:
- 金额:$ 24.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2025-02-28
- 项目状态:未结题
- 来源:
- 关键词:AIDS preventionAcquired Immunodeficiency SyndromeAddressAdherenceAdministrative SupplementAdvocateAleuritesAwarenessBehavior TherapyCaringCenters for Disease Control and Prevention (U.S.)ClinicClinic VisitsCollaborationsCommunitiesCommunity HealthCommunity OutreachCommunity of PracticeCompensationCountyDevelopmentDiagnosisDiscriminationEducationEducational CurriculumEnsureEpidemicEquipment and supply inventoriesEvaluationFailureFeedbackFrightFundingGoalsGuidelinesHIVHIV InfectionsHIV/AIDSHealthHealth CampaignHealth PersonnelHealthcareHealthcare SystemsHuman immunodeficiency virus testImprove AccessIncidenceIndividualInfectionInsuranceInternetKnowledgeLawsLettersLicensingLinkLiteratureLocationMeasuresMedicineMethodsMonitorNewly DiagnosedPatient Self-ReportPersonsPharmaceutical PreparationsPharmacistsPharmacy facilityPoliciesPopulationPreventionPrevention strategyPrivatizationProtocols documentationProviderPublic HealthPublished CommentRecording of previous eventsReportingResearchResearch PriorityResourcesRoleRural CommunitySelf AssessmentServicesStudentsSurveysTelemedicineTestingTrainingTraining and EducationTransportationUnited StatesUnited States National Institutes of HealthUniversitiesUrban CommunityWashingtonWorkacceptability and feasibilitycultural competenceepidemic preparednesserectionexperiencefollow-uphealth care serviceimprovedmembermental health centeronline communitypre-exposure prophylaxispreventprevention serviceprimary outcomeprogramsrecruitrepositoryside effectskillssocial stigmasupportive environmentsynergismuptakevirtualweb site
项目摘要
Project Summary/Abstract
Despite availability of HIV pre-exposure prophylaxis (PrEP) for over a decade, many persons who could benefit
from PrEP have not yet accessed PrEP services. Implementation of pharmacy-based PrEP is a promising
strategy that presents opportunity to overcome barriers related to clinic distance and stigma and to increase
PrEP access, uptake, persistence, and adherence among individuals who would benefit most.
Despite the fact that project team member and pharmacist Dr. Elyse Tung started the first pharmacy-based
PrEP clinic in Seattle nearly ten years ago, PrEP still is not widely available through pharmacies without a
prescription from a licensed doctor or other clinician. As of 2023, not all states allow pharmacists to prescribe
and dispense PrEP without a doctor’s prescription, and many insurance companies erect barriers to providing
compensation to pharmacists for this role. Work is needed to develop and refine the training and educational
support specifically required by pharmacists to expand their scope of practice and to advocate for supportive
policies.
This administrative supplement application to the Ending the HIV Epidemic (EHE) initiative proposes two
specific aims. Aim 1 will establish an online virtual community of practice (VCoP) for pharmacists and
pharmacy staff to increase their knowledge, capabilities, and comfort in prescribing PrEP. The second aim will
outline a comprehensive PrEP curriculum for pharmacists, technicians, and students. Ultimately, the goal of
this supplement is to support sustainable pharmacy-based programs that will increase the number of people
starting and continuing PrEP in EHE jurisdictions across the United States.
This project addresses the Prevent pillar of the EHE plan with a secondary impact on the Diagnose pillar. This
project also addresses the NIH HIV/AIDS Research Priorities (NOT-OD-20-018) to reduce HIV incidence by
testing new prevention strategies and training the HIV workforce. It is in synergy with the local EHE plan (see
Letter of Support from Ms. Hutcheson, EHE Program Manager), the Washington State Department of Health
(see Letter of Support), and the National HIV/AIDS Strategy. The national strategy specifically calls out to
leverage pharmacists’ knowledge and accessibility in nearly every urban and rural community as part of a
comprehensive HIV prevention and care strategy. Ultimately our goal is to provide more PrEP options and
expand access points for PrEP care in locations and to populations disproportionately impacted by HIV
infection.in order to end the HIV epidemic.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Susan Marie Graham其他文献
Susan Marie Graham的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Susan Marie Graham', 18)}}的其他基金
University of Washington Developmental AIDS Research Center for Mental Health (UW ARCH)
华盛顿大学心理健康发展艾滋病研究中心 (UW ARCH)
- 批准号:
10569065 - 财政年份:2021
- 资助金额:
$ 24.91万 - 项目类别:
Shikamana PrEP: A Community Participatory Approach to Integrating PrEP, Sexual Health, and Mental Health Services for GBMSM in Kenya
Shikamana PrEP:肯尼亚 GBMSM 整合 PrEP、性健康和心理健康服务的社区参与方法
- 批准号:
10064644 - 财政年份:2019
- 资助金额:
$ 24.91万 - 项目类别:
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
美国和撒哈拉以南非洲地区缓释抗逆转录病毒药物治疗的可接受性
- 批准号:
10020441 - 财政年份:2019
- 资助金额:
$ 24.91万 - 项目类别:
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
美国和撒哈拉以南非洲地区缓释抗逆转录病毒药物治疗的可接受性
- 批准号:
10214487 - 财政年份:2019
- 资助金额:
$ 24.91万 - 项目类别:
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
美国和撒哈拉以南非洲地区缓释抗逆转录病毒药物治疗的可接受性
- 批准号:
10437700 - 财政年份:2019
- 资助金额:
$ 24.91万 - 项目类别:
Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa
美国和撒哈拉以南非洲地区缓释抗逆转录病毒药物治疗的可接受性
- 批准号:
10678651 - 财政年份:2019
- 资助金额:
$ 24.91万 - 项目类别:
Impact of a novel screening program to detect acute and prevalent HIV infection and reduce HIV transmission
新型筛查计划对检测急性和流行的艾滋病毒感染并减少艾滋病毒传播的影响
- 批准号:
9202511 - 财政年份:2016
- 资助金额:
$ 24.91万 - 项目类别:
Impact of a novel screening program to detect acute and prevalent HIV infection and reduce HIV transmission
新型筛查计划对检测急性和流行的艾滋病毒感染并减少艾滋病毒传播的影响
- 批准号:
9336791 - 财政年份:2016
- 资助金额:
$ 24.91万 - 项目类别:
Endothelial Activation and Microangiopathy in HIV-related Cardiovascular Disease
HIV 相关心血管疾病中的内皮激活和微血管病
- 批准号:
8984228 - 财政年份:2015
- 资助金额:
$ 24.91万 - 项目类别:
相似海外基金
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
10219039 - 财政年份:2020
- 资助金额:
$ 24.91万 - 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9981476 - 财政年份:2019
- 资助金额:
$ 24.91万 - 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
- 批准号:
9364184 - 财政年份:2016
- 资助金额:
$ 24.91万 - 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
- 批准号:
236932 - 财政年份:2011
- 资助金额:
$ 24.91万 - 项目类别:
Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554155 - 财政年份:1991
- 资助金额:
$ 24.91万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
- 批准号:
3554156 - 财政年份:1991
- 资助金额:
$ 24.91万 - 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
- 批准号:
2063342 - 财政年份:1991
- 资助金额:
$ 24.91万 - 项目类别:














{{item.name}}会员




